Icosavax, Inc.
ICVX
Revenue
582.00k
▼-7.22M▼-92.54%
12 Months ChangeAssets
251.30M
▼-17.73M▼-6.59%
3 Months ChangeLiabilities
18.92M
▼-2.39M▼-11.21%
3 Months ChangeFree Cash Flow
-23.22M
▼-4.64M▼-24.97%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-02-20
Form 8-K
ID: 0001104659-24-025251
2023-12-12
Form 8-K
ID: 0001193125-23-293389
2023-11-14
Form 10-Q
ID: 0000950170-23-063857
2023-11-14
Form 8-K
ID: 0001193125-23-277122
2023-08-14
Form 10-Q
ID: 0000950170-23-042438
2023-08-14
Form 8-K
ID: 0001193125-23-212339
2023-08-08
Form 8-K
ID: 0001193125-23-206224
2023-06-09
Form 8-K
ID: 0001193125-23-164490
2023-05-23
Form 8-K
ID: 0001193125-23-151020
2023-05-22
Form 8-K
ID: 0001193125-23-150624